Assy N, Rosser B G, Grahame G R, Minuk G Y
Liver Diseases Unit, Division of Gastroenterology, Department of Medicine, Health Sciences Centre, University of Manitoba, Winnipeg, Canada.
Gastrointest Endosc. 1999 Jun;49(6):690-4. doi: 10.1016/s0016-5107(99)70283-x.
The risk of exacerbating subclinical hepatic encephalopathy associated with the administration of sedative drugs in patients with cirrhosis undergoing diagnostic upper gastrointestinal (GI) endoscopy for portal hypertension remains to be determined.
Ten adult patients with cirrhosis completed number connection tests before sedation for endoscopy and at discharge from the endoscopy unit 2 hours post-procedure. Control patients consisted of five patients with cirrhosis undergoing the same procedure for the same indication who did not receive sedation and 12 patients with no evidence of liver disease who received sedation before diagnostic endoscopy for a variety of GI complaints. The control populations were age, gender, education level, and, in the case of patients with cirrhosis, Child Pugh s score matched to the patients with cirrhosis who received sedation.
The mean (+/- SEM) age of patients with cirrhosis who received sedation was 59.6 +/- 3.8 years. Seven of the ten (70%) were men. Their mean Child Pugh s score was 7.2 +/- 1.5. Nine of the ten (90%) had abnormal baseline number connection tests results (mean for the group 52.3 +/- 6.7 seconds) the extent of which correlated with Child Pugh s scores (p < 0.005). Individually, the baseline number connection tests results were normal in one (10%), mild in six (60%), moderate in one (10%), and severe in two (20%). After the procedure (before discharge) the mean number connection tests result was 61.5 +/- 7.9 seconds (p = 0.01 when compared with baseline). The results were now normal in none (0%), mild in four (40%), moderate in four (40%), and severe in two (20%). Pre- and post-procedure number connection tests results did not change in the non-sedated cirrhotic or sedated non-liver disease control patients.
The results of this study indicate that (1) the majority of patients with cirrhosis and suspected portal hypertension have evidence of subclinical hepatic encephalopathy, (2) the extent of encephalopathy correlates with the Child Pugh's score, (3) sedation with midazolam for upper GI endoscopy exacerbates the encephalopathy, and (4) this adverse effect is still evident 2 hours after the procedure.
对于因门静脉高压接受诊断性上消化道内镜检查的肝硬化患者,给予镇静药物是否会加重亚临床肝性脑病的风险仍有待确定。
10例成年肝硬化患者在内镜检查镇静前及检查后2小时从内镜科室出院时完成数字连接测试。对照组包括5例因相同适应证接受相同检查但未接受镇静的肝硬化患者,以及12例因各种胃肠道不适在诊断性内镜检查前接受镇静且无肝病证据的患者。对照组在年龄、性别、教育水平方面进行匹配,对于肝硬化患者,Child Pugh评分与接受镇静的肝硬化患者相匹配。
接受镇静的肝硬化患者的平均(±标准误)年龄为59.6±3.8岁。10例中有7例(70%)为男性。他们的平均Child Pugh评分为7.2±1.5。10例中有9例(90%)基线数字连接测试结果异常(该组平均值为52.3±6.7秒),其异常程度与Child Pugh评分相关(p<0.005)。个体而言,基线数字连接测试结果正常的有1例(10%),轻度异常的有6例(60%),中度异常的有1例(10%),重度异常的有2例(20%)。检查后(出院前)数字连接测试的平均结果为61.5±7.9秒(与基线相比p=0.01)。此时结果正常的为0例(0%),轻度异常的有4例(40%),中度异常的有4例(40%),重度异常的有2例(20%)。未接受镇静的肝硬化患者或接受镇静的非肝病对照组患者检查前后数字连接测试结果未发生变化。
本研究结果表明:(1)大多数患有肝硬化且疑似门静脉高压的患者有亚临床肝性脑病的证据;(2)肝性脑病的程度与Child Pugh评分相关;(3)上消化道内镜检查使用咪达唑仑镇静会加重肝性脑病;(4)这种不良影响在检查后2小时仍然明显。